Hematologists Accepting Harvard Pilgrim Health Care in Massachusetts
160 verified hematologists in Massachusetts accept Harvard Pilgrim Health Care. Profiles cover focus areas including Hematology & Oncology, Medical Oncology, and Lymphoma. Common hospital affiliations include Dana-Farber Cancer Institute, Dana-Farber/Brigham and Women's Cancer Center, and Brigham and Women's Hospital.
Daniel Deangelo, M.D.,PH.D.
Chief, Division of Leukemia Institute Physician; Professor of Medicine, Harvard Medical School
Hematology
Judy Garber, M.D.
Chair and Chief of the Division of Cancer Genetics and Prevention at Dana-Farber Cancer Institute and a Professor of Medicine at Harvard Medical School.&nb
Hematology
Glenn Hanna, M.D.
Director of the Center for Cancer Therapeutic Innovation (CCTI), the early drug development program at DFCI. His clinical and translational research eff
Hematology
Amir Fathi, M.D.
Professor of Medicine, Harvard Medical School; Program Director, Center for Leukemia, Massachusetts General Hospital
Hematology
Ronald Takvorian, MD
Assistant Professor of Medicine, Harvard Medical School
Hematology
Panagiotis Konstantinopoulos, M.D.
Director of the Mellen and Eisenson Family Center for BRCA and Related Genes and Director of Translational Research, Division of Gynecologic Oncology. He is a; Chair for Clinical and Translational Research at DFCI and Professor of Medicine at Harvard Medical School. His clinical and translational research career f
Hematology
Matthew Davids, M.D.
Director of Clinical Research, as well as Associate Director of the CLL Center. He is also an Associate Professor of Medicine at Harvard Medical School, and a; Director, Clinical Research, Division of Lymphoma
Hematology
Gregory Abel, MD
Director, Older Adult Hematologic Malignancy Program; Senior Physician
Hematology
Kimmie Ng, MD
Professor of Medicine at Harvard Medical School, Associate Chief of the Division of Gastrointestinal Oncology at Dana-Farber Cancer Institute (DFCI), and the F; Director of the Young-Onset Colorectal Cancer Center at DFCI. Her research focuses on identifying dietary and molecular predictors of colorectal cancer risk a
Hematology
Caron Jacobson, MD
Director, Immune Effector Cell Therapy Program; Senior Physician
Hematology
Philippe Armand, MD, PHD
Chief, Division of Lymphoma
Hematology
John Koreth, MBBS DPHIL
Professor of Medicine, Harvard Medical School; Director of Translational Research, Stem Cell Transplantation Program; Director, Immune Toxicities Program
Hematology
Jon Aster, MD PHD
Chief, Hematopathology, Brigham and Women's Hospital; Professor of Pathology, Harvard Medical School
Hematology
Jacob Sands, MD
Chief, Lowe Center for Thoracic Oncology; Director, International Patient Center
Hematology
Jennifer Brown, MD PHD
Director, CLL Center, Division of Hematologic Malignancies, Dana-Farber Cancer Institute; Worthington and Margaret Collette Professor of Medicine in the Field of Hematologic Oncology, Harvard Medical School
Hematology
Alexi Wright, MD
Associate Professor of Medicine at Harvard Medical School and Dana-Farber Cancer Institute. She received her Medical Degree from University of Pennsylvania a
Hematology
Robb Friedman, M.D.
Director, Outpatient Services, Dana-Farber Brigham Cancer Center at South Shore Health
Hematology
Margaret Shipp, MD
Chief of the Division of Hematologic Neoplasia at DFCI, the Director of the Lymphoma and Myeloma Program of the Dana-Farber/Harvard Cancer Center and a Pro; Chair in Lymphoma
Hematology
Kenneth Bauer, M.D.
Professor of Medicine, Harvard Medical School
Hematology
Natalie Sinclair, MD
Director, Dana-Farber Brigham Cancer Center
Hematology
Browse hematologists accepting Harvard Pilgrim Health Care by city
Drill into a specific Massachusetts city.